Nanoparticles targeting breast cancer cell during radiotherapy.

Nanoparticles and Breast Cancer: A Revolutionary Approach to Radiotherapy

Samir D’Costa monogram
Samir D’Costa in Health & Wellness October 2026 • 3 min read.

"Explore how gold and other nanoparticles are enhancing radiotherapy for breast cancer, offering hope for more effective and less toxic treatments."


Breast cancer remains a significant health challenge worldwide, ranking as one of the most common malignancies among women. In 2012, the estimated incidence rate was 123.2 per 100,000, with a mortality rate of 30.9 per 100,000. Treating breast cancer requires a coordinated, multidisciplinary approach, including surgeons, clinical oncologists, and radiation oncologists.

Radiation oncology has evolved, with trends favoring breast-conserving surgery and evidence-based practices that improve disease control and cosmetic outcomes. This evolution has solidified radiation therapy as a cost-effective cornerstone of treatment.

A primary goal in radiotherapy is enhancing radiation delivery while minimizing harm to healthy tissue. Advances in technology have improved toxicity profiles in organs like the skin, lungs, and heart. However, making radiation more effective while sparing healthy tissue remains a challenge.

AI Search Multiple angles on this topic

Evidence Context

No source material was provided for current statistics or population impact. Accordingly, no numerical estimate or firm conclusion about nanoparticles and breast-cancer radiotherapy can be supported here. Any assessment should be treated as provisional until directly relevant evidence is supplied.

Treatment Context

No sources were provided describing standard radiotherapy methods or their limitations. This subsection therefore cannot establish comparative benefits, risks, or accepted clinical practice. Claims about nanoparticles should remain appropriately qualified without directly relevant evidence.

Historical Context

No source material was supplied for the historical development of nanoparticle-based radiotherapy. Specific milestones, discoveries, and dates therefore cannot be verified here. A reliable historical account would require sources focused on those subjects.

How Do Nanoparticles Boost Radiotherapy's Effectiveness?

Nanoparticles targeting breast cancer cell during radiotherapy.

Researchers have been exploring the use of metal nanoparticles, particularly gold, to amplify the radiation response within tumors. This approach aims to deliver a more potent dose of radiation to cancer cells while reducing the impact on surrounding healthy tissue. Though clinical data is still emerging, preclinical studies offer promising insights.

A dosimetric study by Cho et al. suggested that incorporating gold nanoparticles (AuNP) with Ir192 brachytherapy could increase the treatment dose by 40% due to gold's high atomic number and increased photoelectric absorption. The benefit may be limited in megavoltage (MV) treatments, where the Compton Effect is predominant.

  • Gold Nanoparticles (AuNP): The most studied material, showing promise in enhancing radiation effects due to its high atomic number.
  • Silver Nanoparticles (AgNP): Some studies suggest they may have better interactions with MV radiation, triggering pair production.
  • Bismuth-Based Particles: Developed and tested in murine breast cancer models, showing good clinical results without significant toxicity.
AI Search Multiple angles on this topic

Research Evidence

No sources were provided for recent research or reviews on nanoparticles and breast-cancer radiotherapy. The available material does not support conclusions about current laboratory findings, clinical trials, or review consensus. Those questions require directly relevant oncology sources.

Limits of Comparison

The supplied sources concern familial natural short sleep and short sleeper syndrome rather than nanoparticles or radiotherapy. They describe a rare inherited trait in which people sleep fewer hours without daytime sleepiness, while Cleveland Clinic describes short sleeper syndrome as needing six or fewer hours while feeling rested. These sources therefore cannot substantiate a counterargument or failure related to nanoparticle-based breast-cancer treatment.

Comparative Evidence

No source material was provided for comparing nanoparticles with conventional breast-cancer radiotherapy. Relative effectiveness, safety, precision, and accessibility therefore cannot be assessed from the supplied evidence. Any comparison would require matched clinical or preclinical sources.

Other research compares AuNP to cisplatin, a common chemotherapy drug, both of which act as radiosensitizers. Zheng et al. found that combining AuNP and cisplatin with radiation increased DNA double-strand breaks by 7.5 times, compared to a 3-fold increase with a single sensitizer.

The Future of Nanoparticle-Enhanced Radiotherapy

The use of nanoparticles as radiosensitizers holds significant promise for future cancer treatments. As ongoing research matures, it will be crucial to determine whether these enhancements can lead to dose reductions in radiotherapy without compromising treatment outcomes. Clinical data will ultimately reveal the full potential of this innovative approach.

AI Search Multiple angles on this topic

Evidence Mismatch

The supplied sources focus on norovirus, not nanoparticle-based radiotherapy. They consistently describe norovirus as a contagious infection associated with vomiting and diarrhea, and one source identifies hydration as the main treatment. This information cannot support expert commentary on breast-cancer radiotherapy.

Future Evidence

No sources were supplied for future developments in nanoparticle-enabled radiotherapy. Potential research directions, timelines, and clinical prospects therefore cannot be stated responsibly. Relevant oncology research would be needed to support a forward-looking assessment.

Systemic Context

No source material was provided on regulatory, economic, ethical, or access challenges affecting nanoparticle-based radiotherapy. These systemic issues cannot be characterized from the evidence supplied. Further analysis should rely on sources addressing healthcare implementation directly.

Technology Support

The supplied Microsoft sources address software support rather than patients receiving nanoparticle-based radiotherapy. Microsoft states that keeping Edge updated helps provide security updates, performance enhancements, and new browser features. This material cannot establish the human or real-world impact of nanoparticle treatment.

What gold nanoparticle dose modeling can tell us

The review describes gold as the most studied particle in this area, while noting that other materials have been used in preclinical work. This signals a varied research field, not established clinical use.[1]

What limits the nanoparticle evidence

  • The review says its assessment is based on dosimetric evidence and treats effects on treatment choices and patient outcomes as probable, not established.[1]
  • The review reports that safety evidence was not available to support active use, despite encouraging laboratory and animal dosimetry findings.[1]
  • The review characterizes clinical evidence as insufficient for routine use or disease-specific management, despite multiple preclinical studies.[1]
  • The review’s positive outlook rests on in vitro and in vivo dosimetry; it does not supply safety evidence for use in patients.[1]

The review's evidence and scope

PopulationBreast cancer tissue[1]
SettingPreclinical settings[1]
Main outcomeDosimetric data in breast cancer tissue and probable future impact in treatment choices and patient outcomes[1]
Times cited7[1]

What a follow-up study would need to resolve

  • What safety evidence would be needed to assess whether dosimetric enhancement can translate into patient treatment choices and outcomes?[1]

Sources

  1. Enhancing radiotherapy effect in breast cancer with nanoparticles: A review (VM Media SP. zo.o VM Group SK, 2019)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.rpor.2018.10.003, Alternate LINK

Title: Enhancing Radiotherapy Effect In Breast Cancer With Nanoparticles: A Review

Subject: Radiology, Nuclear Medicine and imaging

Journal: Reports of Practical Oncology & Radiotherapy

Publisher: VM Media SP. zo.o VM Group SK

Authors: Gustavo R. Sarria, Miguel Ángel Berenguer Francés, Isabel Linares Galiana

Published: 2019-01-01

Everything You Need To Know

1

How do Gold Nanoparticles (AuNP) enhance radiotherapy for breast cancer?

Gold Nanoparticles (AuNP) enhance radiotherapy by amplifying the radiation response within the tumor. Because of gold's high atomic number, it increases photoelectric absorption, allowing for a more potent dose of radiation to be delivered to cancer cells. Studies have shown that incorporating Gold Nanoparticles (AuNP) with radiotherapy can increase the treatment dose, potentially leading to improved outcomes while minimizing harm to healthy tissue. This is because the nanoparticles concentrate in the tumor, maximizing the radiation effect where it is needed most.

2

What are the potential benefits of using nanoparticles in breast cancer treatment?

The primary benefit of using nanoparticles, such as Gold Nanoparticles (AuNP), Silver Nanoparticles (AgNP), and Bismuth-Based Particles, is to enhance the effectiveness of radiotherapy while reducing the harm to healthy tissue. By acting as radiosensitizers, these nanoparticles amplify the radiation's effect on cancer cells. This approach could potentially lead to dose reductions in radiotherapy without compromising treatment outcomes, offering a more targeted and less toxic approach to cancer treatment. The use of Bismuth-Based Particles has shown good clinical results without significant toxicity.

3

How do Silver Nanoparticles (AgNP) compare to Gold Nanoparticles (AuNP) in radiotherapy?

Silver Nanoparticles (AgNP) are being investigated for their potential in radiotherapy, particularly for their interaction with megavoltage (MV) radiation. While Gold Nanoparticles (AuNP) are the most studied, Silver Nanoparticles (AgNP) may trigger pair production, which is a different mechanism that can enhance radiation effects. Further research is needed to determine the specific advantages and effectiveness of Silver Nanoparticles (AgNP) compared to Gold Nanoparticles (AuNP) in enhancing radiotherapy.

4

What is the role of Bismuth-Based Particles in breast cancer treatment?

Bismuth-Based Particles have shown promising results in preclinical studies using murine breast cancer models. These particles have demonstrated the ability to enhance the effects of radiotherapy without causing significant toxicity. This suggests that Bismuth-Based Particles could be a viable and safe alternative to other nanoparticles, such as Gold Nanoparticles (AuNP) or Silver Nanoparticles (AgNP). The potential of Bismuth-Based Particles underlines the diversity of materials being explored to improve cancer treatment outcomes.

5

How does the combination of Gold Nanoparticles (AuNP) and chemotherapy compare to using a single radiosensitizer?

The combination of Gold Nanoparticles (AuNP) and chemotherapy, such as cisplatin, has shown a significant increase in treatment effectiveness compared to using a single radiosensitizer. Research has indicated that combining Gold Nanoparticles (AuNP) and cisplatin with radiation can lead to a substantial increase in DNA double-strand breaks in cancer cells. This suggests a synergistic effect, where the combined approach amplifies the radiation’s impact, potentially leading to more effective cancer cell destruction. Zheng et al. found that the combination of AuNP and cisplatin with radiation increased DNA double-strand breaks by 7.5 times, compared to a 3-fold increase with a single sensitizer.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.